The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

UCLA School of Medicine- Divison of Endocrinology, Los Angeles

University of CA at SanDiego- Department of Endocrinology, San Diego

Boehringer Ingelheim Investigational Site, Westlake Village

Boehringer Ingelheim Investigational Site, Chicago

University of Rochester Medical Center, Rochester

Boehringer Ingelheim Investigational Site, Cincinnati

Boehringer Ingelheim Investigational Site, Nashville

Boehringer Ingelheim Investigational Site, Harker Heights

University of Manitoba, Diabetes Research Group, Winnipeg

St. Joseph's Health Care London, London

The Ottawa Hospital - Riverside Campus, Ottawa

Århus Sygehus, Aarhus C

Universitätsmedizin Berlin, Berlin

Boehringer Ingelheim Investigational Site, Künzing

Boehringer Ingelheim Investigational Site, Unterschneidheim

Policlinico Monteluce, Perugia

Azienda Ospedale Università di Pisa, Pisa